在可溶性甲基酸环酶上的NO独立调节部位
J P Stasch1, E M Becker, C Alonso-Alija
1Pharma Research Center, Bayer AG, Aprather Wey 18a, D-42096 Wuppertal, Germany. johannes-peter.stasch.js@bayer-ag.de
Nature
|March 10, 2001
概括
研究人员发现了一种新的方法来刺激可溶性酸环酶 (sGC) 独立于氧化 (NO). 这种新的方法显示了通过降低血压和提高生存率来治疗心血管疾病的前景.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 氧化 (NO) 是一个关键的生物媒介,参与血管扩张.
- 溶性酸环酶 (sGC) 通过将GTP转化为循环GMP (cGMP) 来调解NO诱导的血管扩张.
- 现有的关于NO和sGC的研究逐渐阐明了它们在生理和病理生理过程中的作用.
研究的目的:
- 在sGC上确定一个新的监管网站.
- 发现新的独立于NO的sGC刺激剂.
- 评估一种新的sGC刺激器对心血管疾病的治疗潜力.
主要方法:
- 照相亲和度标签被用来识别sGC的α1子单元上的调节部位.
- 一种pyrazolopyridine化合物,BAY 41-2272,被合成并测试其刺激sGC的能力.
- BAY 41-2272的效果在低NO的高血压大鼠模型中进行了评估.
主要成果:
- 在sGC的α1亚单元上发现了一种涉及氨酸238和氨酸243的新型调节部位.
- 发现BAY 41-2272通过该部位强烈刺激sGC,独立于NO.
- BAY 41-2272在高血压的老鼠模型中表现出抗血小板活性,降低血压,并增加存活率.
结论:
- 发现了一种刺激sGC的新型NO独立机制.
- BAY 41-2272代表了一种具有潜在心血管益处的新型sGC刺激剂类.
- 这种方法可能为治疗心血管疾病提供一个新的治疗策略,特别是那些涉及低NO水平的心血管疾病.
更多相关视频
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
07:15Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025
相关概念视频
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: